Substance / Medication

Methylergometrine

Overview

Active Ingredient
methylergonovine
RxNorm CUI
6883

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of methylergometrine during the early puerperium: a randomized double-blind placebo-controlled clinical trial.
Sparice Stefania, Giampaolino Pierluigi, Sansone Anna et al. · J Matern Fetal Neonatal Med · 2020
PMID: 30257588RCT
[Effects of methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section].
Kikutani Takehiko, Kikutani Mariko, Oshima Masayuki et al. · Masui · 2006
PMID: 16715913RCT
Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh Gunjan, Radhakrishnan Gita, Guleria Kiran · Int J Gynaecol Obstet · 2009
PMID: 19628206Observational
Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor.
Chhabra Shakuntala, Tickoo Chandan · J Obstet Gynaecol Res · 2008
PMID: 18834340Observational
Oral misoprostol versus injectable methylergometrine in management of the third stage of labor.
Garg P, Batra S, Gandhi G · Int J Gynaecol Obstet · 2005
PMID: 16126208Observational
Second-degree atrioventricular block after administration of methylergometrine for treatment of uterine atony during cesarean section.
Torres Dios J Á, Pérez Benítez S · Rev Esp Anestesiol Reanim (Engl Ed) · 2021
PMID: 34521612Case Report
Methylergometrine-Induced Myocardial Infarction in the Setting of a Cesarean Delivery.
Fayed Mohamed, Buffington Branden, Ibrahim Rowaa et al. · Cureus · 2021
PMID: 35003941Case ReportFull text (PMC)
Reversible cerebral vasoconstriction syndrome with limb myoclonus following intravenous administration of methylergometrine.
Ishibashi Tomoko, Ishibashi Satoru, Uchida Tokujiro et al. · J Anesth · 2011
PMID: 21431624Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Methylergometrine (substance)
SNOMED CT
126074008
UMLS CUI
C0025760
RxNorm CUI
6883

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.